Pricing Log in Create free account

IGC Pharma, Inc. (IGC) vs Seres Therapeutics, Inc. (MCRB)

IGC Pharma, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. IGC Pharma, Inc. and Seres Therapeutics, Inc. are of similar size ($22.0M and $20.8M). IGC Pharma, Inc. grew revenue faster over the last twelve months: −17.0% against −98.3%. IGC Pharma, Inc. has the higher net margin (−836.1% vs −2,209.6%) and the higher return on invested capital (−90.5% vs −1,267.8%). Across the 18 metrics below, IGC Pharma, Inc. leads on 12 and Seres Therapeutics, Inc. on 6.

Valuation

Metric IGC MCRB Biotechnology median
P/E n/m n/m 10.60
P/S 18.89 9.25 9.40
P/B 3.20 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 19.31 49.24 9.02
Earnings yield (47.37%) (253.88%) (32.88%)
Free cash flow yield (27.39%) (323.94%) (23.13%)

Profitability

Metric IGC MCRB Biotechnology median
Gross margin 23.89% 100.00% 68.51%
Operating margin (914.80%) (3,656.89%) 0.00%
Net margin (836.06%) (2,209.55%) 0.00%
Free cash flow margin (485.92%) (2,997.74%) 0.00%
Return on equity (126.16%) (144.35%) (51.96%)
Return on assets (94.55%) (44.85%) (46.06%)
Return on invested capital (90.48%) (1,267.77%) 0.00%

Growth

Metric IGC MCRB Biotechnology median
Revenue growth (TTM) (17.03%) (98.33%) 6.76%
EPS growth (last fiscal year) 57.85% 0.00% 29.88%
Revenue growth, 5-year CAGR (20.77%) (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IGC MCRB Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 0.42 1.65 4.97
Net debt to EBITDA 0.04 0.51 1.01

Dividend

Metric IGC MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IGC MCRB Biotechnology median
Market cap 21.95m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack